State Street’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $188K | Hold |
115,934
| – | – | ﹤0.01% | 3853 |
|
|
2025
Q1 | $83.2K | Hold |
115,934
| – | – | ﹤0.01% | 4006 |
|
|
2024
Q4 | $129K | Hold |
115,934
| – | – | ﹤0.01% | 3941 |
|
|
2024
Q3 | $81.2K | Hold |
115,934
| – | – | ﹤0.01% | 4017 |
|
|
2024
Q2 | $116K | Sell |
115,934
-541,773
| -82% | -$542K | ﹤0.01% | 3964 |
|
|
2024
Q1 | $1.56M | Buy |
657,707
+49,700
| +8% | +$118K | ﹤0.01% | 3356 |
|
|
2023
Q4 | $1.37M | Buy |
608,007
+2,100
| +0.3% | +$4.73K | ﹤0.01% | 3410 |
|
|
2023
Q3 | $1.28M | Sell |
605,907
-23,379
| -4% | -$49.6K | ﹤0.01% | 3461 |
|
|
2023
Q2 | $1.94M | Buy |
629,286
+578,173
| +1,131% | +$1.79M | ﹤0.01% | 3424 |
|
|
2023
Q1 | $275K | Buy |
51,113
+1,200
| +2% | +$6.46K | ﹤0.01% | 3954 |
|
|
2022
Q4 | $332K | Buy |
49,913
+8,700
| +21% | +$57.9K | ﹤0.01% | 3909 |
|
|
2022
Q3 | $164K | Hold |
41,213
| – | – | ﹤0.01% | 4223 |
|
|
2022
Q2 | $205K | Sell |
41,213
-241,863
| -85% | -$1.2M | ﹤0.01% | 4184 |
|
|
2022
Q1 | $1.71M | Buy |
283,076
+17,891
| +7% | +$108K | ﹤0.01% | 3628 |
|
|
2021
Q4 | $3.08M | Buy |
265,185
+29,062
| +12% | +$338K | ﹤0.01% | 3477 |
|
|
2021
Q3 | $3.7M | Buy |
236,123
+34,320
| +17% | +$538K | ﹤0.01% | 3390 |
|
|
2021
Q2 | $3.76M | Buy |
201,803
+32,272
| +19% | +$602K | ﹤0.01% | 3371 |
|
|
2021
Q1 | $7.31M | Buy |
+169,531
| New | +$7.31M | ﹤0.01% | 2878 |
|